Mitochondrial disease patient motivations and barriers to participate in clinical trials.

Background: Clinical treatment trials are increasingly being designed in primary mitochondrial disease (PMD), a phenotypically and genetically heterogeneous collection of inherited multi- system energy deficiency disorders that lack effective therapy. We sought to identify motivating factors and barriers to clinical trial participation in PMD.

Methods: A survey study was conducted in two independent mitochondrial disease subject cohorts.